Table 4.
Univariate and multivariate analyses of variables associated with GPC3-positive HCC.
Univariable | Multivariable | |||
---|---|---|---|---|
OR (95%CI) | P Value | OR (95%CI) | P Value | |
Tumor c (m/s) | 0.484 (0.181, 0.816) | *0.01 | 0.361 (0.158, 0.826) | *0.02 |
Tumor φ (rad) | 0.277 (0.036, 2.106) | 0.22 | ||
Liver c (m/s) | 0.903 (0.283, 2.882) | 0.86 | ||
Liver φ (rad) | 0.236 (0.019, 2.983) | 0.26 | ||
Sex | ||||
Male | 1 | |||
Female | 0.362 (0.076, 1.719) | 0.20 | ||
Age | 0.982 (0.941, 1.025) | 0.42 | ||
BMI | 0.914 (0.787, 1.061) | 0.24 | ||
Size | 0.967 (0.820, 1.139) | 0.69 | ||
Albumin (g/dL) | 0.989 (0.889, 1.101) | 0.84 | ||
Total bilirubin (umol/L) | 1.062 (0.977, 1.155) | 0.15 | ||
INR unit | 0.516 (0.004, 64.255) | 0.79 | ||
AFP (ng/mL) | *0.001 | 8.117 (2.422, 27.199) | *0.001 | |
<20 | 1 | |||
≥20 | 7.667 (2.384, 24.650) | |||
CEA (ng/mL) | ||||
<5 | 1 | |||
≥5 | 0.615 (0.105, 3.612) | 0.59 | ||
CA125 (U/ml) | ||||
<24 | 1 | |||
≥24 | 1.145 (0.334, 3.927) | 0.83 | ||
CA199 (U/ml) | ||||
<25 | 1 | |||
≥25 | 0.938 (0.334, 2.635) | 0.90 | ||
Non-rim APHE | ||||
Absent | 1 | |||
Present | 2.296 (0.721, 7.315) | 0.16 | ||
Nonperipheral washout | ||||
Absent | 1 | |||
Present | 0.588 (0.226, 1.533) |
0.28 | ||
Enhancing capsule | ||||
Absent | 1 | |||
Present | 0.978 (0.376, 2.542) |
0.96 | ||
LI-RADS | ||||
Non-LR-5 | 1 | |||
LR-5 | 1.214 (0.437, 3.374) | 0.71 |
*P < 0.05.